
Sign up to save your podcasts
Or


Recently, the American Association of Clinical Endocrinology and the American Association for the Study of Liver Diseases released guideline updates on nonalcoholic steatohepatitis (NASH). How will these updates impact clinical practice? Drs. Zobair M.Younossi and Scott D. Isaacs join Dr. Charles Turck to share their insights on these updated guidelines.
By ReachMD4.7
1818 ratings
Recently, the American Association of Clinical Endocrinology and the American Association for the Study of Liver Diseases released guideline updates on nonalcoholic steatohepatitis (NASH). How will these updates impact clinical practice? Drs. Zobair M.Younossi and Scott D. Isaacs join Dr. Charles Turck to share their insights on these updated guidelines.

2,058 Listeners

695 Listeners

496 Listeners

69 Listeners

1 Listeners

3 Listeners

3 Listeners

0 Listeners

6 Listeners

15 Listeners

0 Listeners

0 Listeners

2,442 Listeners

3,332 Listeners

56,419 Listeners

1,153 Listeners

513 Listeners

252 Listeners

217 Listeners

13 Listeners

18 Listeners

33 Listeners